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Standardized EEG interpretation
accurately predicts prognosis after
cardiac arrest
ABSTRACT
Objective: To identify reliable predictors of outcome in comatose patients after cardiac arrest
using a single routine EEG and standardized interpretation according to the terminology pro-
posed by the American Clinical Neurophysiology Society.
Methods: In this cohort study, 4 EEG specialists, blinded to outcome, evaluated prospectively re-
corded EEGs in the Target Temperature Management trial (TTM trial) that randomized patients to
33°C vs 36°C. Routine EEG was performed in patients still comatose after rewarming. EEGs
were classified into highly malignant (suppression, suppression with periodic discharges, burst-
suppression), malignant (periodic or rhythmic patterns, pathological or nonreactive background),
and benign EEG (absence of malignant features). Poor outcome was defined as best Cerebral
Performance Category score 3–5 until 180 days.
Results: Eight TTM sites randomized 202 patients. EEGs were recorded in 103 patients at a
median 77 hours after cardiac arrest; 37% had a highly malignant EEG and all had a poor out-
come (specificity 100%, sensitivity 50%). Any malignant EEG feature had a low specificity to
predict poor prognosis (48%) but if 2 malignant EEG features were present specificity increased
to 96% (p , 0.001). Specificity and sensitivity were not significantly affected by targeted tem-
perature or sedation. A benign EEG was found in 1% of the patients with a poor outcome.
Conclusions: Highly malignant EEG after rewarming reliably predicted poor outcome in half of
patients without false predictions. An isolated finding of a single malignant feature did not predict
poor outcome whereas a benign EEG was highly predictive of a good outcome. Neurology®
2016;86:1482–1490
GLOSSARY
ACNS 5 American Clinical Neurophysiology Society; CPC 5 Cerebral Performance Category scale; CI 5 confidence inter-
vals; SSEP 5 somatosensory evoked potentials; TTM 5 Target Temperature Management; WLST 5 withdrawal of life-
sustaining therapy.
Out-of-hospital cardiac arrest is common1 and most patients remain unconscious after restora-
tion of spontaneous circulation. Approximately half of these patients will die during the hospital
stay, the majority from hypoxic-ischemic brain injury.2
Intensive care is usually continued until a prediction of poor outcome is made, based on clin-
ical neurologic examination, commonly combined with other prognostic tools.3,4 EEG is the
most widely used prognostic tool to support a clinical examination and is accessible in most
hospitals5; it is recommended for both prognostication and ruling out subclinical seizures.6,7
There is no high-level evidence for predicting poor prognosis using EEG and meta-analysis of
available data is confounded by the wide variety of classification systems used.8–10 Other draw-
backs of EEG include interrater variability11,12 and the confounding effects of ongoing or
residual sedation.
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The American Clinical Neurophysiology
Society (ACNS) has proposed a standardized
critical care EEG terminology13 to facilitate
multicenter studies and maximize interrater
reliability. We used this recently revised termi-
nology to evaluate prospectively recorded
EEGs in the Target Temperature Manage-
ment (TTM) trial, which randomized 950 pa-
tients to 33°C vs 36°C controlled temperature
after cardiac arrest and reported no differences
in mortality or neurocognitive function.14,15
Using the ACNS terminology, we defined
highly malignant EEG patterns16 and found
substantial interrater and intrarater agreement.11
The main objective of this study was to evaluate
whether the proposed highly malignant EEG
patterns reliably predict a poor neurologic out-
come for patients who remain in a coma after
cardiac arrest. Moreover, we explored the prog-
nostic performance of malignant and benign
EEG patterns.16
METHODS The TTM trial randomized 950 adult comatose
patients resuscitated after out-of-hospital cardiac arrest of
presumed cardiac cause from November 2010 to January 2013.
Standard protocol approvals, registrations, and patient
consents. The trial protocol17 was approved by the ethics com-
mittees in the participating countries and registered at
ClinicalTrials.gov (NCT01020916). Consent was obtained
from a legal surrogate and from each patient regaining mental
capacity.
Sedation was mandatory during temperature management
and tapered at normothermia if not needed for intensive care rea-
sons or treatment of status epilepticus.17
A routine EEG was performed during office hours 12–36
hours after rewarming in patients who were still comatose, typi-
cally corresponding to 48–72 hours after the cardiac arrest or later
if this period coincided with a weekend. The detailed rationale of
the present EEG study, including the prespecified hypotheses,
was published previously.16 All 36 intensive care units in Europe
and Australia participating in the TTM trial performed routine
EEGs.
For this EEG study, we included all patients from sites that
had an EEG system allowing EEG data export including nota-
tions on reactivity testing. Patients who awoke or died before
the recommended time point of EEG were excluded. Sedation,
antiepileptic medication, and level of consciousness were docu-
mented prospectively.14,17
At 72 hours after rewarming, a physician blinded to target
temperature, but not to the local EEG report, performed a neu-
rologic evaluation and recommended continuation or withdrawal
of life-sustaining therapy (WLST).17–19 Persisting deep coma
(Glasgow Coma Scale: motor 1–2) was a criterion of poor prog-
nosis and allowed WLST if combined with either bilateral loss of
somatosensory evoked potentials (SSEP) N20 responses or
treatment-refractory status epilepticus.17 Treatment refractory
was defined as unresponsive to propofol, midazolam, or thiopen-
tal in combination with at least 1 IV antiepileptic substance for at
least 24 hours. In addition, a clinical finding of early status myoc-
lonus, regardless of EEG correlate, in combination with bilateral
loss of N20 potentials after rewarming was a criterion of poor
prognosis. In patients not fulfilling these criteria, continued active
intensive care was protocolized and patients reevaluated daily.
The details and rationale of the prognostication algorithm and
how WLST was implemented in the trial was published.14,17–19
EEGs were retrieved as electronic data format files to a central
EEG database and analyzed using the ACNS standardized termi-
nology,13 independently by 4 EEG specialists (Sweden: E.W.,
Denmark: T.W.K., The Netherlands: A.-F.v.R., and Switzerland:
A.O.R.). The EEG specialists were blinded to all clinical data
including outcome and reported EEG findings through a Web-
based electronic case report form structured to assure complete
data. The EEGs were full-length (.20 minutes) and at least 16
EEG channels were used. Based on the findings regarding peri-
odic or rhythmic patterns, background pattern, and reactivity, the
EEGs were classified according to the prespecified hypotheses
into the following categories:
1. Highly malignant EEG (figure 1)
• Suppressed background without discharges
• Suppressed background with continuous periodic
discharges
• Burst-suppression background with or without discharges
2. Malignant EEG
• Malignant periodic or rhythmic patterns (abundant periodic
discharges; abundant rhythmic polyspike-/spike-/sharp-and-
wave; unequivocal electrographic seizure)
• Malignant background (discontinuous background; low-
voltage background; reversed anterior-posterior gradient)
• Unreactive EEG (absence of background reactivity or only
stimulus-induced discharges)
3. Benign EEG (absence of all malignant features stated above)
Surviving patients attended a follow-up 180 days after their
cardiac arrest by a blinded assessor.14 Outcome was dichotomized
according to the Cerebral Performance Category scale (CPC).20
Good neurologic outcome was defined as CPC 1–2 (no or mod-
erate disability) at follow-up or at any time during the hospital
stay. Poor outcome was defined as best achieved CPC of 3–5
(severely disabled, comatose, or deceased).
Prognostic ability (specificity, sensitivity) was calculated for the
highly malignant patterns (primary hypothesis) and the other pre-
specified patterns (secondary hypotheses) and is presented as the
mode value for the 4 interpreters, i.e., the pattern that 2 or more
interpreters have reported, with 95% confidence intervals (CI). If
2 interpreters reported 1 pattern and the other 2 interpreters re-
ported another, the most malignant pattern was assigned.
For comparisons among temperature groups, sedation, and
EEG patterns, we applied generalized linear mixed models includ-
ing interpretations from all 4 EEG specialists.
Statistical analysis was performed using R, version 3.0.2.
RESULTS Eight study sites randomized 202 patients
to targeted temperature management at 33°C (n5 103)
or 36°C (n 5 99). A routine EEG was recorded at a
median 77 hours (interquartile range 53–102) after car-
diac arrest in 103 patients still comatose after rewarming.
Exclusion and inclusion in the present study is
described in figure 2. In 99 of the 202 randomized
patients, 69 of whom awoke and 22 died before the
recommended time point of prognostication, EEGs
were not performed.
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Eight patients with prolonged coma (.5 days) did
not have an EEG. One of these was brain dead and 2
had absent N20 potentials. In the remaining 5 pa-
tients, the reason for missing EEG was unclear. Two
of these patients did not have WLST and eventually
recovered to CPC 3, 1 died on day 5 of cerebral cause
without WLST, 1 died on day 6 due to multiorgan
failure without WLST, and 1 died on day 5 of cere-
bral cause after WLST.
The patients’ characteristics are presented in table 1.
Patients with EEG were more likely to have a poor
outcome.
Characteristics of the patients on the day of EEG
registration are presented in table 2. At this time point
the majority were deeply comatose. Clinical seizures
occurred during the EEG recording in 16%, mostly
myoclonus, and 35% of patients had antiepileptic
treatment.
Highly malignant EEG. The prognostic ability of the
highly malignant patterns is presented in table 3 (pri-
mary hypotheses). A highly malignant pattern was
reported by the majority of the 4 interpreters (mode
value) in 38 patients (37%) and all had a poor
neurologic outcome. The sensitivity for a highly
malignant pattern to predict a poor outcome was
50% (mode value). Sensitivity varied among the 4
interpreters but specificity was 100% for all individ-
ual interpreters (table e-1 on the Neurology® Web site
at Neurology.org).
Malignant EEG. The prognostic ability of the malig-
nant features is presented in table 3. A malignant
EEG, defined as presence of at least one malignant fea-
ture and thus also including the highly malignant
patterns, was reported in 89 patients (86%). The sensi-
tivity to predict a poor outcome was 99% with a spec-
ificity of 48% (mode values). Sensitivity and specificity
varied considerably among the 4 interpreters (table e-1).
Regarding the subcategories of malignant features, any
malignant periodic or rhythmic pattern showed a higher
specificity (100%) to predict a poor outcome compared
to any malignant background pattern (74%) or a non-
reactive EEG (70%). An isolated finding of a single
malignant feature occurred in 30 patients, 17 of whom
had a good outcome.
If at least 2 of the 3 malignant subcategories were
present in the same EEG, the specificity to predict a
Figure 1 Highly malignant EEG patterns
Highly malignant patterns used in the study defined according to the standardized EEG terminology by the American Clin-
ical Neurophysiology Society. (A) Suppressed background (amplitude ,10 mV, 100% of the recording) without discharges.
(B) Suppressed background with superimposed continuous periodic discharges. (C) Burst-suppression (periods of suppres-
sion with amplitude ,10 mV constituting .50% of the recording) without discharges. (D) Burst-suppression with super-
imposed discharges.
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poor outcome increased significantly to 96% (p ,
0.001), while sensitivity decreased to 76% (p, 0.001).
Benign EEG. Fourteen patients (14%) had a benign
EEG, defined as a lack of all malignant features. Of
these, 13 (93%) had a good outcome. A benign
EEG was found in 1% (95% CI 0%–7%) of the 76
patients with a poor outcome and in 48% (95% CI
31%–66%) of the 27 patients with a good outcome.
Eight patients (8%) had a benign and reactive
EEG, defined as absence of all malignant features
and presence of reactivity to either sound or pain
stimuli, and none of these patients had a poor out-
come. A benign and reactive EEG was found in none
(95% CI 0%–5%) of the patients with a poor out-
come and in 30% (95% CI 16%–49%) of the
patients with a good outcome.
The ability for a benign EEG to predict good out-
come did not significantly differ compared to that of a
benign and reactive EEG (p 5 0.08) in this small
sample size.
Level of target temperature management. There were no
significant differences between patients treated
with 33°C compared to 36°C regarding prevalence
or prognostic ability of highly malignant EEG
(prevalence p 5 0.58; sensitivity p 5 0.58; speci-
ficity p 5 not applicable) or malignant EEG
(prevalence p 5 0.17; sensitivity p 5 0.64; speci-
ficity p 5 0.81).
Sedation. Ongoing or residual sedation affected the
level of consciousness in 56% of the patients on the
day of the routine EEG, according to the treating
physician. In 36%, sedation was ongoing during
recording of the EEG. There were no significant dif-
ferences regarding prognostic ability of highly malig-
nant EEG (sensitivity p 5 0.81; specificity p 5 not
applicable) or malignant EEG (sensitivity p 5 0.44;
specificity p 5 0.21) between patients with ongoing
sedation and those without ongoing sedation.
DISCUSSION EEG is a standard investigation to
assess prognosis after cardiac arrest, but its reliability
may be limited by lack of consensus on definitions
of malignant patterns8–10 and by interrater variabil-
ity.11,12 We found that the proposed highly malignant
EEG patterns reliably predicted a poor outcome in
our cohort of comatose post–cardiac arrest patients.
These patterns were previously found to have substan-
tial interrater and intrarater reliability11 and the sensi-
tivity to detect patients with poor prognosis was 50%,
exceeding that of SSEP and absent ocular reflexes.19
Since routine EEG is a generally available, noninvasive
examination, these findings, if verified in a different
cohort, may enhance the safe use of EEG as a key
Figure 2 Study flow chart of exclusion from and inclusion into the study
The recommended time point of prognostication was 72 hours after rewarming, corresponding to approximately 108 hours
after the cardiac arrest. The most probable cause of death according to the treating physician is reported (cerebral, multi-
organ failure, or cardiovascular). Eight study sites were included since they had an EEG system that allowed export of EEG
data that included notations regarding testing of reactivity.
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component in decisions on continuation or withdrawal
of life-sustaining therapy. Nevertheless, it is strongly
advisable to combine the EEG findings with other tests
to perform a multimodal prognostication.7
Standardization of EEG interpretation is critical
for reproducibility of clinical studies, meta-analyses,
and application of these results into everyday clinical
practice. Therefore, the use of an international well-
defined terminology, such as the ACNS EEG termi-
nology, is strongly recommended.
The highly malignant patterns used in this study
were strictly defined according to the ACNS EEG ter-
minology and adhere closely to previously described
malignant patterns.8–10
Our secondary hypothesis that a malignant EEG
should nearly always be associated with a poor out-
come16 was discarded due to lack of specificity and
considerable variability between interpreters. Our re-
sults therefore discourage the use of isolated findings
of a malignant feature in decisions on WLST. Com-
bination of at least 2 malignant features from diverse
malignant subcategories significantly increased the
specificity to 96%, indicating that such combina-
tions, if confirmed in another cohort, may be of use
to predict a poor prognosis.
Low-voltage background (most background activity
,20 mV) was a common pattern with several false-
positive predictions, in contrast to the highly malignant
pattern of suppressed background (all background activ-
ity ,10 mV), which had a specificity of 100% for
predicting poor outcome. This is of considerable impor-
tance since 20 mV has been used as a limit of the back-
ground voltage for predicting a poor outcome.8–10,21,22
Our results highlight that the degree of discontinu-
ity is an important predictor of prognosis. A discontin-
uous background (suppression periods constituting
10%–49%) resulted in some false-positives (for 2
individual interpreters) while a burst-suppression
Table 1 Patient characteristics
EEG performed (n 5 103) All patients (n 5 202)
Age, y, mean 6 SD 67 6 10 67 6 11
Male, n (%) 80 (78) 160 (79)
Comorbidities before randomization, n (%)
Ischemic heart disease 32 (31) 53 (26)
Arterial hypertension 57 (55) 92 (46)
Previous transient ischemic attack or stroke 11 (11) 18 (9)
Diabetes mellitus 17 (17) 35 (17)
Asthma or chronic obstructive pulmonary disease 12 (12) 20 (10)
Epilepsy 1 (1) 2 (1)
Malignancy 2 (2) 2 (1)
Pre–cardiac arrest CPC 1a 96 (93) 187 (93)
Pre–cardiac arrest CPC 2 7 (7) 14 (7)
Cardiac arrest–related variables
Bystander witnessed cardiac arrest, n (%) 96 (93) 181 (90)
Shockable first rhythm,b n (%) 74 (72) 151 (75)
Time to return of spontaneous circulation,c min, median (IQR) 30 (21–45) 26 (18–43)
Admission variables, n (%)
Glasgow Coma Scale (motor), median (IQR) 1 (1–2) 1 (1–3)
Seizures before cardiac arrest 1 (1) 5 (2)
Seizures after resuscitation 3 (3) 5 (2)
Randomized to TTM 33°C, n (%) 52 (50) 103 (51)
Outcome
Poor neurologic outcome,d n (%) 76 (74) 109 (54)
Abbreviations: CPC 5 Cerebral Performance Category scale; IQR 5 interquartile range; TTM 5 Target Temperature
Management.
a Pre–cardiac arrest CPC was unknown for one patient.
bVentricular fibrillation, nonperfusing ventricular tachycardia, or unknown rhythm responsive to shock.
c For unwitnessed arrests, time intervals were calculated from emergency call to event.
dBest CPC 3–5 during hospital stay or at follow-up 180 days after the cardiac arrest.
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background (suppression periods constituting 50%–
99%) was a reliable predictor of poor prognosis for
all 4 interpreters. This is in concordance with a recent
retrospective single-center study using the same stan-
dardized ACNS terminology that found a zero false-
positive rate for burst-suppression to predict a poor
outcome.22 However, that study also reported no
false-positives for a low-voltage background 24 hours
after cardiac arrest or later, which was not the case in
our study using 4 interpreters from different centers.
A proposed malignant pattern is the alpha-theta
coma pattern,23–25 which has a nonreactive back-
ground with a reversed anterior-posterior gradient
(pathologic distribution of the background activity).
A reversed anterior-posterior gradient could per se not
reliably predict a poor outcome in our study.
There is no consensus on the definition of posta-
noxic electrographic seizure activity, but several inves-
tigators using different definitions have shown a strong
correlation to poor outcome.26–30 All 5 patients who
had unequivocal electrographic seizure activity during
the limited time period of the routine EEG had a poor
outcome in this study. In contrast, abundant periodic
discharges were not inevitably associated with a poor
outcome for the individual interpreters (table e-1), but
no patients with periodic discharges on a suppressed
background (,10 mV) according to any interpreter
had a good outcome.
The treatment of epileptiform activity was not
defined in the protocol and not included in the interven-
tion of this trial. Whether patients with electrographic
status epilepticus may benefit from antiepileptic medica-
tion is unclear and currently addressed in a separate ran-
domized trial.31 Since continuous EEG monitoring was
not available in most centers of this study, it is likely that
some patients with intermittent electrographic seizures
were missed.
It is well-known that EEG activity is affected by
sedation32 and in sufficient doses it may cause burst-
suppression, but whether sedation in clinically used
doses affects the prognostic value of malignant EEG
patterns is unknown. Lacking detailed data on the
amount of sedation used, we found that the majority
of patients were still considered affected by sedation by
the reporting physician at the time of EEG, which is
close to the recommended time point for neurologic
prognostication in recent guidelines.7 However, the
predictive ability of our malignant patterns was not
significantly affected by ongoing sedation.
Background reactivity was previously found to have
strong prognostic implications in several single-center
studies.23,33–35 We found only fair interrater agreement
for this variable among our 4 interpreters.11 It is there-
fore not surprising that the specificity for an unreactive
EEG varied considerably among our interpreters. False
predictions of a poor outcome ranged from none to the
majority of patients among the interpreters. This
might reflect different traditions in assessing reactivity
in different centers, since the interpreter who had the
highest specificity also had the lowest sensitivity and
vice versa. A more conservative approach when stating
absence of reactivity by the former interpreter com-
pared to the latter may partly explain the differences.
More strict definitions, standardized stimuli, video re-
cordings, bedside assessments, use of muscle relaxants,
or quantitative measurements36 could possibly improve
agreement and specificity. Awareness of the limitations
of reactivity as a prognostic tool is important.
We termed EEGs that lacked anymalignant features
as benign, according to our prespecified definitions.
The proportion of patients with a poor outcome who
had a benign EEG was very low (1%), which is an
important finding since few markers indicating a good
prognosis are available. However, it is important to rec-
ognize that many patients with good outcome lacked a
benign EEG due to presence of some malignant EEG
features and that the definition of good outcome in-
cludes a significant proportion of patients with mild
cognitive impairment.37
An important limitation of our study is that the
local EEG report was available at the neurologic evalu-
ation. Although treatment-refractory postanoxic status
Table 2 Patient characteristics on the day of
EEG recording (n 5 103)
Values
Time to EEG, hours after cardiac
arrest, median (IQR)
77 (53–102)
Variables on day of EEG
GCS motor, median (IQR)a 2 (1–3)
Myoclonic seizures, n (%) 31 (30)
Tonic/clonic seizures, n (%) 9 (9)
Variables during EEG, n (%)
Ongoing clinical seizures 16 (16)
Myoclonic seizures 10 (10)
Tonic/clonic seizures 1 (1)
Ongoing sedation 37 (36)
Propofol 26 (25)
Midazolam 7 (7)
Pentothal/thiopental 0 (0)
Other (clonidine, ketobemidone,
fentanyl, remifentanil)
16 (16)
Ongoing antiepileptic medication 36 (35)
Monotherapy 27 (26)
Combinations 9 (9)
Abbreviations: GCS 5 Glasgow Coma Scale; IQR 5
interquartile range.
a Patients not assessable due to sedation were excluded.
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epilepticus was the only EEG criterion that justified
withdrawal of treatment according to the TTM trial
protocol,17 other EEG features in the local EEG report
may have had influence, causing a self-fulfilling proph-
ecy. Importantly, all 4 EEG readers in this study were
blinded to outcome and all clinical data.
Another limitation is that our EEG investigations
are limited to patients who failed to wake up when
the active temperature control phase was over. Thus
we lack data on spontaneously awakening patients,
but we hypothesize that the occurrence of malignant
EEG patterns would be highly unlikely in awake pa-
tients. Exclusion of early awakening patients with
favorable prognosis38 explains the worse prognosis
among patients with EEG recordings in our study.
Yet this cohort is likely to be representative of coma-
tose patients eligible for an EEG for prognostication
after cardiac arrest.
The power of the study is limited by the exclusion
of sites that could not export EEG data of reactivity.
This selection of centers allows for homogenous
high-quality data and the possibility to confirm find-
ings, apart from reactivity, in the remaining cohort.
We recruited our EEG specialists from different coun-
tries and centers without prior collaboration, which
would increase the generalizability of our results. We
recognize that all 4 EEG readers are specialists in clin-
ical neurophysiology with 10–14 years of experience in
reading EEGs and that we cannot conclude on the
transferability of our results to less experienced readers.
All EEGs were performed after rewarming and the
majority within 2–4 days after the cardiac arrest and
we stress that our results are representative for this
time period only. It has previously been shown that
some of our malignant patterns can occur during the
early phase after resuscitation and ongoing target tem-
perature management among survivors with good
outcome.26,39
A highly malignant EEG pattern, defined accord-
ing to the standardized ACNS EEG terminology, pre-
dicted poor outcome in half of patients who remained
in a coma after rewarming without false-positives. If
replicated in a larger cohort, ideally with blinding of
the EEGs to the treating physician, these patterns
are promising candidates to be included in a multi-
modal prognostication algorithm. On the other hand,
an isolated finding of a single malignant feature could
not be used to predict poor outcome. For these pa-
tients, prognostication must rely on other methods.
A benign EEG was conversely highly predictive of a
Table 3 Ability of highly malignant and malignant patterns to predict poor outcome
No. (%)
(n 5 103) Sensitivity Specificity
True-
positive
False-
positive
True-
negative
False-
negative
EEG patterns
‡1 highly malignant patterna 38 (37) 50 (39–61) 100 (88–100) 38 0 27 38
Suppressed background without discharges 19 (18) 25 (17–36) 100 (88–100) 19 0 27 57
Suppressed background with continuous PDs 4 (4) 5 (2–13) 100 (88–100) 4 0 27 72
Burst-suppression (suppression >50%) 15 (15) 20 (12–30) 100 (88–100) 15 0 27 61
‡1 malignant featureb 89 (86) 99 (93–100) 48 (31–66) 75 14 13 1
‡2 malignant featuresc 59 (57) 76 (66–85) 96 (82–99) 58 1 26 18
Malignant periodic or rhythmic pattern 33 (32) 43 (33–55) 100 (88–100) 33 0 27 43
Abundant PDs 30 (29) 40 (29–51) 100 (88–100) 30 0 27 46
Abundant rhythmic spike-and-wave 4 (4) 5 (2–13) 100 (88–100) 4 0 27 72
Unequivocal seizure 5 (5) 7 (3–15) 100 (88–100) 5 0 27 71
Malignant background 69 (67) 82 (71–89) 74 (55–87) 62 7 20 14
Discontinuous (suppression >10%) 43 (42) 57 (45–67) 100 (88–100) 43 0 27 33
Low-voltage 52 (50) 65 (53–74) 89 (72–96) 49 3 24 27
Reversed anterior-posterior gradient 12 (12) 13 (7–23) 93 (77–98) 10 2 25 66
Unreactive EEGd 65 (63) 88 (78–94) 70 (48–86) 59 6 14 8
Abbreviation: PD 5 periodic discharge.
Sensitivity and specificity presented as mode values of the 4 interpreters with 95% confidence intervals. True-positives 5 tested pattern is present and
outcome is poor; false-positives 5 tested pattern is present and outcome is good; true-negatives 5 tested pattern is absent and outcome is good; false-
negatives 5 tested pattern is absent and outcome is poor.
a Suppressed background without discharges; suppressed background with continuous periodic discharges; burst-suppression.
bAbundant periodic discharges; abundant rhythmic spike-and-wave; unequivocal seizure; discontinuous background; low-voltage background; reversed
anterior-posterior gradient; unreactive EEG.
c From different malignant subcategories (malignant periodic or rhythmic patterns; malignant background; unreactive EEG) present in the same EEG.
dReactivity for both pain and sound stimuli was tested in 87 patients.
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good functional outcome. Neither the level of tem-
perature management nor ongoing sedation in clini-
cally used doses significantly affected the prognostic
ability of these patterns.
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